Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Cellular and Molecular Medicine Année : 2012

Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?

Résumé

Cardiovascular diseases remain an important cause of morbi-mortality. Atherosclerosis, which predisposes to cardiovascular disorders such as myocardial infarction and stroke, develops silently over several decades. Identification of circulating biomarkers to evaluate cardiovascular event risk and pathology prognosis is of particular importance. Microparticles (MPs) are small vesicles released from cells upon apoptosis or activation. Microparticles are present in blood of healthy individuals. Studies showing a modification of their concentrations in patients with cardiovascular risk factors and after cardiovascular events identify MPs as potential biomarkers of disease. Moreover, the pathophysiological properties of MPs may contribute to atherosclerosis development. In addition, pharmacological compounds, used in the treatment of cardiovascular disease, can reduce plasma MP concentrations. Nevertheless, numerous issues remain to be solved before MP measurement can be applied as routine biological tests to improve cardiovascular risk prediction. In particular, prospective studies to identify the predictive values of MPs in pathologies such as cardiovascular diseases are needed to demonstrate whether MPs are useful biomarkers for the early detection of the disease and its progression.
Fichier principal
Vignette du fichier
jcmm1486.pdf (164.08 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

inserm-00656089 , version 1 (03-01-2012)

Identifiants

Citer

Morgane Baron, Chantal M. Boulanger, Bart Staels, Anne Tailleux. Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?. Journal of Cellular and Molecular Medicine, 2012, 16 (7), pp.1365-76. ⟨10.1111/j.1582-4934.2011.01486.x⟩. ⟨inserm-00656089⟩
98 Consultations
222 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More